dc.contributor.author | Pérez-García, Felipe | |
dc.contributor.author | Jimenez-Sousa, Maria Angeles | |
dc.contributor.author | Gómez-Sánchez, Esther | |
dc.contributor.author | Gonzalo-Benito, Hugo | |
dc.contributor.author | Fernandez-Rodriguez, Amanda | |
dc.contributor.author | Lorenzo-López, Mario | |
dc.contributor.author | Heredia-Rodríguez, María | |
dc.contributor.author | Martínez de Paz, Pedro | |
dc.contributor.author | Gómez-Pesquera, Estefanía | |
dc.contributor.author | Tamayo, Eduardo | |
dc.contributor.author | Resino, Salvador | |
dc.date.accessioned | 2022-05-05T11:52:51Z | |
dc.date.available | 2022-05-05T11:52:51Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | J Microbiol Immunol Infect. 2022; 55(2022): 540-544.. | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/14278 | |
dc.description.abstract | We carried out a retrospective exploratory study on 173 patients who underwent major surgery and developed septic shock after surgery. Our findings suggest that CEACAM7 rs1001578, rs10409040, and rs889365 polymorphisms could influence septic shock-related death in individuals who underwent major surgery. | es_ES |
dc.description.sponsorship | This work has been supported by grants given by Instituto de Salud Carlos III (grant number PI15/01451 to ET), “Gerencia de Salud, Consejería de Sanidad, Junta de Castilla y Leon” [grant number GRS 463/A/10 and 773/A/13 to ET], and PFIZER [grant number CT25-ESP01-01 to SR]. MAJS and AFR are supported by “Instituto de Salud Carlos III” [grant numbers CP17CIII/00007 and CP14CIII/00010, respectively] | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Elsevier | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | CEACAM7 | es_ES |
dc.subject | Major surgery | es_ES |
dc.subject | SNPs | es_ES |
dc.subject | Septic shock | es_ES |
dc.subject | Survival | es_ES |
dc.title | CEACAM7 polymorphisms predict genetic predisposition to mortality in post-surgical septic shock patients | es_ES |
dc.type | journal article | es_ES |
dc.rights.license | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.identifier.pubmedID | 34657826 | es_ES |
dc.format.volume | 55 | es_ES |
dc.format.number | 2022 | es_ES |
dc.format.page | 540 | es_ES |
dc.identifier.doi | 10.1016/j.jmii.2021.09.006 | es_ES |
dc.contributor.funder | Instituto de Salud Carlos III | es_ES |
dc.contributor.funder | Junta de Castilla y León (España) | es_ES |
dc.contributor.funder | Pfizer | es_ES |
dc.description.peerreviewed | Sí | es_ES |
dc.identifier.e-issn | 1995-9133 | es_ES |
dc.relation.publisherversion | https://doi.org/10.1016/j.jmii.2021.09.006 | es_ES |
dc.identifier.journal | Journal of Microbiology, Immunology, and Infection | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.rights.accessRights | open access | es_ES |
dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/null/null/Subprograma de proyectos de investigacion en salud (AES 2015). Modalidad proyectos en salud. (2015)/PI15/01451 | es_ES |
dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/CP17CIII/00007 | es_ES |
dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/CP14CIII/00010 | es_ES |